Furthermore, a dynamic transcriptomic analysis identified that suppression of the PGC1α–ERRα axis, a critical component of the mitochondrial biogenesis pathway, is associated with the myogenesis defect in FSHD [42]. The gene discussed is PPARGC1A; the disease is facioscapulohumeral muscular dystrophy.